1-6 of 6
Yvette Norden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exploratory Results of PET-CT and Residual Lymph Node Fine Needle Aspiration of Patients Treated with First-Line Venetoclax and Ibrutinib for CLL/Sll; First Interim Analysis of the Phase 2 HOVON 158/Next STEP Trial

Mark-David Levin, Sabina Kersting, Julie M.N. Dubois, Yvette Norden, Johan A Dobber, Yvonne W.S. Jauw, Anne-Marie van der Kevie-Kersemaekers, Clemens Mellink, Koen de Heer, Leonie van der Burg, Doreen Te Raa, Fransien de Boer, Jolanda Droogendijk, Cecile Idink, Marten R. Nijziel, Lidwine W. Tick, Inge Ludwig, Matthijs Silbermann, Aart Beeker, Mar Bellido, Ludo M. Evers, Gerben JC Zwezerijnen, Carsten U Niemann, Arnon P. Kater
Journal: Blood
Blood (2022) 140 (Supplement 1): 4137–4139.
https://doi.org/10.1182/blood-2022-163209
Published: 2022
Journal Articles

The HOVON 100 Study in Adult Acute Lymphoblastic Leukemia Re-Analysed By Multi-State Modeling: Benefits and Risks of Clofarabine

Sjoerd J.F. Hermans, Yvette Norden, Jurjen Versluis, Anita W. Rijneveld, Okke De Weerdt, Bart J. Biemond, Arjan A. van de Loosdrecht, Lotte E. Van der Wagen, Mar Bellido, Michel Van Gelder, Walter J.F.M. Van der Velden, Dominik Selleslag, Danielle van Lammeren, Vincent H.J. van der Velden, Liesbeth C. de Wreede, Douwe Postmus, Francesco Pignatti, Jan J. Cornelissen
Journal: Blood
Blood (2022) 140 (Supplement 1): 8890–8892.
https://doi.org/10.1182/blood-2022-163055
Published: 2022
Journal Articles

First Line Treatment with Venetoclax and Ibrutinib Induction Followed By Obinutuzumab Intensification Exclusively in CLL/SLL Patients Not in Complete Remission and/or with Detectable Bone Marrow Minimal Residual Disease (NEXT STEP trial)

Sabina Kersting, MD PhD, Mark-David Levin, MD PhD, Carsten Utoft Niemann, MD PhD, Yvette Norden, PhD, Arnon P. Kater, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1753.
https://doi.org/10.1182/blood-2019-124550
Published: 2019
Journal Articles

Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial

Fie Juhl Vojdeman, MD, Lone Bredo Pedersen, Doreen Te Raa, MD PhD, Vesa Juvonen, PhD, Yvette Norden, Geir Erland Tjønnfjord, MD DMsc, Eva Kimby, Maija Itälä-Remes, MD PhD, Anton W Langerak, Ludo M. Evers, Thorsten Zenz, MD, Marinus H.J. Van Oers, MD PhD, Christian H. Geisler, MD PhD, Arnon P. Kater, MD, Carsten Utoft Niemann, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4312.
https://doi.org/10.1182/blood.V130.Suppl_1.4312.4312
Published: 2017
Journal Articles

Efficacy and Safety of First-Line Therapy with Chlorambucil, Rituximab and Individualized Dose Lenalidomide in FCR-Unfit Patients with Advanced Chronic Lymphocytic Leukemia (CLL): A Phase I/II HOVON Trial

Arnon P. Kater, MD, Marinus H.J. H.J. Van Oers, MD PhD, Yvette Norden, Roberto D. Liu, Martin R. Schipperus, Martine Chamuleau, MD PhD, Marcel Nijland, MD, Jeanette K. Doorduijn, MD PhD, Michel van Gelder, MDPhD, Mels Hoogendoorn, MDPhD, Fransien Croon-de Boer, Shulamit Wittebol, Martijn Kerst, MDPhD, Willem Marijt, Ward Posthuma, MD PhD, Reinier Raymakers, MDPhD, Ron Schaafsma, MDPhD, Johan Dobber, Sabina Kersting, MDPhD, Mark-David Levin
Journal: Blood
Blood (2017) 130 (Supplement 1): 4328.
https://doi.org/10.1182/blood.V130.Suppl_1.4328.4328
Published: 2017
Journal Articles

Prospective Molecular MRD Detection By NGS: A Powerful Independent Predictor for Relapse and Survival in Adults with Newly Diagnosed AML

Mojca Jongen-Lavrencic, MD PhD, Tim Grob, MD, Francois G. Kavelaars, Adil S.A. Al Hinai, Annelieke Zeilemaker, Claudia A.J. Erpelinck-Verschueren, Yvette Norden, Rosa Meijer, PhD, Bart J. Biemond, MD PhD, Carlos Graux, Marinus van Marwijk Kooij, MD PhD, Markus G. Manz, MD, Thomas Pabst, MD PhD, Violaine Havelange, MD PhD, Jakob R. Passweg, MD PhD, Gert J. Ossenkoppele, MD PhD, Gerrit Jan Schuurhuis, PhD, Mathijs A. Sanders, PhD, Bob Löwenberg, MD PhD, Peter J.M. Valk, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): LBA-5.
https://doi.org/10.1182/blood.V130.Suppl_1.LBA-5.LBA-5
Published: 2017